Antitrust Waiting Period Expires on Allscripts-Misys Merger Agreement

June 2nd, 2008 | Computer & Electronics , Computer Software , Internet , Technology | 0 Comments »

Regulatory Hurdle Clears Way for Approval of Merger

CHICAGO (June 02, 2008) –

Allscripts, the leading provider of clinical software, connectivity and information solutions that physicians use to improve healthcare, announced today that the waiting period under the Hart-Scott-Rodino (HSR) Antitrust Improvements Act of 1976, with respect to the merger agreement announced on March 18, 2008 between Allscripts and Misys Healthcare to form Allscripts-Misys Healthcare Solutions, Inc., has expired.

(Logo: http://www.newscom.com/cgi-bin/prnh/20061005/ALLSCRIPTSLOGO-b)

The expiration of the Hart-Scott-Rodino waiting period satisfies one of the closing conditions. The transaction remains subject to other customary closing conditions.

Misys Healthcare is a division of Misys plc (FTSE: MSY.L), the global applications software and services company.

About Allscripts

Allscripts (Nasdaq: MDRX) is the leading provider of clinical software, connectivity and information solutions that physicians use to improve healthcare. The company’s unique solutions inform, connect and transform healthcare, delivering improved care at lower cost. More than 40,000 physicians and thousands of other healthcare professionals in clinics, hospitals and extended care facilities nationwide utilize Allscripts to automate everyday tasks such as writing prescriptions, documenting patient care, managing billing and scheduling, and safely discharging patients, as well as to connect with key information and stakeholders in the healthcare system. To learn more, visit Allscripts at http://www.allscripts.com.

This announcement may contain forward-looking statements about Allscripts Healthcare Solutions that involve risks and uncertainties. These statements are developed by combining currently available information with Allscripts beliefs and assumptions. Forward-looking statements do not guarantee future performance. Because Allscripts cannot predict all of the risks and uncertainties that may affect it, or control the ones it does predict, Allscripts’ actual results may be materially different from the results expressed in its forward-looking statements. For a more complete discussion of the risks, uncertainties and assumptions that may affect Allscripts, see the Company’s 2007 Annual Report on Form 10-K, available through the Web site maintained by the Securities and Exchange Commission at www.sec.gov.

SOURCE Allscripts
-0- 06/02/2008
/CONTACT: Dan Michelson, Chief Marketing Officer, +1-312-506-1217,
dan.michelson@allscripts.com, or Todd Stein, Senior Manager-Public Relations,
+1-312-506-1216, todd.stein@allscripts.com, or Bill Davis, Chief Financial
Officer,
+1-312-506-1211, bill.davis@allscripts.com, all of Allscripts/
/Photo: http://www.newscom.com/cgi-bin/prnh/20061005/ALLSCRIPTSLOGO-b
AP Archive: http://photoarchive.ap.org
PRN Photo Desk, photodesk@prnewswire.com/
/Web site: http://www.allscripts.com /
(MDRX MSY.L)

CO: Allscripts; Misys Healthcare
ST: Illinois
IN: CPR STW HEA MTC
SU: TNM

AB-PD
— AQM106 —
5405 06/02/2008 11:32 EDT http://www.prnewswire.com

Source: Allscripts